P-donor ligand containing ruthenium half-sandwich complexes as protein kinase inhibitors

Inorganica Chimica Acta

Volumn 377, Issue 1, 2011, Pages 34-41

  Streu, Craig ^a   Feng, Li ^b   Carroll, Patrick J ^a   Maksimoska, Jasna ^a,c   Marmorstein, Ronen ^a,c   Meggers, Eric ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c WISTAR INSTITUTE   (United States)

Author keywords

Inhibitors; Metal based drugs; Phosphine ligands; Protein kinases; Ruthenium

Indexed keywords

EID: 80053892300     PISSN: 00201693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ica.2011.07.032     Document Type: Article

References (29)

1. For metal complexes with bioactivities, see for example: C. Orvig, and M.J. Abrams Chem. Rev. 99 1999 2201
2. Z. Guo, and P.J. Sadler Angew. Chem., Int. Ed. 38 1999 1512
3. W.H. Ang, and P.J. Dyson Eur. J. Inorg. Chem. 2006 4003
4. T.W. Hambley Science 318 2007 1392
5. R. Alberto J. Organomet. Chem. 692 2007 1179
6. T.W. Hambley Dalton Trans. 2007 4929
7. E. Meggers Chem. Commun. 2009 1001
8. C.L. Davies, E.L. Dux, and A.-K. Duhme-Klair Dalton Trans. 2009 10141
9. C.G. Hartinger, and P.J. Dyson Chem. Soc. Rev. 2009 38, 391
10. R.H. Fish Aust. J. Chem. 63 2010 1505
11. E.A. Hillard, and G. Jaouen Organometallics 30 2011 20
12. G. Gasser, I. Ott, and N. Metzler-Nolte J. Med. Chem. 54 2011 3
13. This is for example illustrated by a review of drugs approved by the US Food and Drug Administration during 2007 in which not a single compound contains a metal atom. See: B. Hughes Nat. Rev. Drug Discov. 7 2008 107
14. For a very recent example, see: L. Feng, Y. Geisselbrecht, S. Blanck, A. Wilbuer, G.E. Atilla-Gokcumen, P. Filippakopoulos, K. Kräling, M.A. Celik, K. Harms, J. Maksimoska, R. Marmorstein, G. Frenking, S. Knapp, L.-O. Essen, and E. Meggers J. Am. Chem. Soc. 133 2011 5976
15. E. Meggers Curr. Opin. Chem. Biol. 11 2007 287
16. D.S. Williams, G.E. Atilla, H. Bregman, A. Arzoumanian, P.S. Klein, and E. Meggers Angew. Chem., Int. Ed. 44 2005 1984
17. G.E. Atilla-Gokcumen, D.S. Williams, H. Bregman, N. Pagano, and E. Meggers ChemBioChem 7 2006 1443
18. J.É. Debreczeni, A.N. Bullock, G.E. Atilla, D.S. Williams, H. Bregman, S. Knapp, and E. Meggers Angew. Chem., Int. Ed. 45 2006 1580
19. K.S.M. Smalley, R. Contractor, N.K. Haass, A.N. Kulp, G.E. Atilla-Gokcumen, D.S. Williams, H. Bregman, K.T. Flaherty, M.S. Soengas, E. Meggers, and M. Herlyn Cancer Res. 67 2007 209
20. G.E. Atilla-Gokcumen, L. Di Costanzo, and E. Meggers Biol. Inorg. Chem. 6 2011 45
21. H. Bregman, P.J. Carroll, and E. Meggers J. Am. Chem. Soc. 128 2006 877
22. G. Manning, D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam Science 298 2002 1912
23. T.P. Gill, and K.R. Mann Organometallics 1 1982 485
24. H. Bregman, D.S. Williams, G.E. Atilla, P.J. Carroll, and E. Meggers J. Am. Chem. Soc. 126 2004 13594
25. (a) H. Bregman, D.S. Williams, E. Meggers, Synthesis (2005) 1521.
26. N. Pagano, J. Maksimoska, H. Bregman, D.S. Williams, R.D. Webster, F. Xue, and E. Meggers Org. Biomol. Chem. 5 2007 1218
27. J. Maksimoska, L. Feng, K. Harms, C. Yi, J. Kissil, R. Marmorstein, and E. Meggers J. Am. Chem. Soc. 130 2008 15764
28. S.O. Meakin, and E.M. Shooter Trends Neurosci. 15 1992 323
29. N. Pagano, E.Y. Wong, T. Breiding, H. Liu, A. Wilbuer, H. Bregman, Q. Shen, S.L. Diamond, and E. Meggers J. Org. Chem. 74 2009 8997